Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:32
|
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [31] Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM)
    Bhide, P.
    Kulkarni, A.
    Dilgil, M.
    Dhir, P.
    Shah, A.
    Gudi, A.
    Homburg, R.
    HUMAN REPRODUCTION, 2016, 31 : 58 - 58
  • [32] Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
    Somunkiran, Asli
    Yavuz, Tevfik
    Yucel, Oguz
    Ozdemir, Ismail
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 134 (02) : 196 - 201
  • [33] Circulating Anti-Mullerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome
    Olszanecka-Glinianowicz, Magdalena
    Zachurzok, Agnieszka
    Drosdzol-Cop, Agnieszka
    Bozetowicz-Wikarek, Maria
    Owczarek, Aleksander
    Gawlik, Aneta
    Chudek, Jerzy
    Skrzypulec-Plinta, Violetta
    Malecka-Tendera, Ewa
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 85 (06): : 372 - 378
  • [34] Intrafollicular anti-Mullerian hormone (AMH) levels positively correlate with follicle sensitivity to follicle stimulating hormone (FSH) and are elevated in polycystic ovary syndrome, (PCOS).
    Dumesic, D. A.
    Lesnick, T. G.
    Bucher, J.
    Wong, A.
    Ball, G. D.
    Abbott, D. H.
    FERTILITY AND STERILITY, 2007, 88 : S26 - S27
  • [35] Serum anti-Mullerian hormone and polycystic ovary syndrome: a matter of methods?
    Parco, S.
    Novelli, C.
    Princi, T.
    MINERVA PEDIATRICA, 2014, 66 (04) : 335 - 336
  • [36] Serum Anti-Mullerian Hormone Levels Decrease after Metformin Administration in Women with Polycystic Ovary Syndrome More in Patients with Lean PCOS Despite Their Normal Levels of Insulin Resistance
    Sauerbrun, May-Tal
    Keltz, Martin
    Lederman, Matthew
    Vega, Mario
    Stein, Daniel
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 180A - 180A
  • [37] Anti-Mullerian hormone levels and features of polycystic ovary syndrome in adolescence
    Caanen, M.
    Peters, H.
    van Hooff, M.
    Lambalk, C.
    HUMAN REPRODUCTION, 2016, 31 : 58 - 58
  • [38] Serum Anti-Mullerian Hormone Levels Are Negatively Associated with Risk Factors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
    van Houten, E. Leonie A. F.
    Kevenaar, Marlies E.
    Louwers, Yvonne V.
    van Dorp, Wendy
    Themmen, Axel P. N.
    Laven, Joop S. E.
    Visser, Jenny A.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [39] Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Mullerian hormone levels
    Vagios, Stylianos
    Sacha, Caitlin R.
    Hammer, Karissa C.
    Dimitriadis, Irene
    James, Kaitlyn E.
    Bormann, Charles L.
    Souter, Irene
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2021, 38 (07) : 1827 - 1833
  • [40] Low vitamin D3 and high anti-Mullerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?
    Cappy, Helene
    Giacobini, Paolo
    Pigny, Pascal
    Bruyneel, Aude
    Leroy-Billiard, Maryse
    Dewailly, Didier
    Catteau-Joriard, Sophie
    ANNALES D ENDOCRINOLOGIE, 2016, 77 (05) : 593 - 599